The global network antenatal corticosteroids trial: impact on stillbirth
Robert L Goldenberg, Vanessa R Thorsten, Fernando Althabe, Sarah Saleem, Ana Garces, Waldemar A Carlo, Omrana Pasha, Elwyn Chomba, Shivaprasad Goudar, Fabian Esamai, Nancy F Krebs, Richard J Derman, Edward A Liechty, Archana Patel, Patricia L Hibberd, Pierre M Buekens, Marion Koso-Thomas, Menachem Miodovnik, Alan H Jobe, Dennis D Wallace, José M Belizán, Elizabeth M McClure, Robert L Goldenberg, Vanessa R Thorsten, Fernando Althabe, Sarah Saleem, Ana Garces, Waldemar A Carlo, Omrana Pasha, Elwyn Chomba, Shivaprasad Goudar, Fabian Esamai, Nancy F Krebs, Richard J Derman, Edward A Liechty, Archana Patel, Patricia L Hibberd, Pierre M Buekens, Marion Koso-Thomas, Menachem Miodovnik, Alan H Jobe, Dennis D Wallace, José M Belizán, Elizabeth M McClure
Abstract
Background: Antenatal corticosteroids are commonly used to reduce neonatal mortality, but most research to date has been in high-resource settings and few studies have evaluated its impact on stillbirth. In the Antenatal Corticosteroids Trial (ACT), a multi-country trial to assess impact of a multi-faceted intervention including antenatal corticosteroids to reduce neonatal mortality associated with preterm birth, we found an overall increase in 28-day neonatal mortality and stillbirth associated with the intervention.
Methods: The ACT was a cluster-randomized trial conducted in 102 clusters across 7 research sites in 6 countries (India [2 sites], Pakistan, Zambia, Kenya, Guatemala and Argentina), comparing an intervention to train birth attendants at all levels of the health system to identify women at risk of preterm birth, administer corticosteroids and refer women at risk. Because of inadequate gestational age dating, the <5(th) percentile birth weight was used as a proxy for preterm birth. A pre-specified secondary outcome of the trial was stillbirth.
Results: After adjusting for the pre-trial imbalance in stillbirth rates, the ACT intervention was associated with a non-significant increased risk of stillbirth (aRR 1.08, 95 % CI, 0.99-1.17, p-0.073). Additionally, the stillbirth rate was higher in the term births (1.20 95 % CI 1.06-1.37, 0.004) and among those with signs of maceration (RR 1.18 (1.04-1.35), p = 0.013) in the intervention vs. control clusters. Differences in obstetric care favored the control clusters and maternal infection was likely more common in the intervention clusters.
Conclusions: In this pragmatic trial, limited data were available to identify the causes of the increase in stillbirths in the intervention clusters. A higher rate of stillbirth in the intervention clusters prior to the trial, differences in obstetric care and an increase in maternal infection are potential explanations for the observed increase in stillbirths in the intervention clusters during the trial.
Trial registration: clinicaltrials.gov (NCT01084096).
References
- Althabe F, Belizán JM, McClure EM, Hemingway-Foday J, Berrueta M, Mazzoni A, et al. A population-based, multifaceted strategy to implement antenatal corticosteroid treatment versus standard care for the reduction of neonatal mortality due to preterm birth in low-income and middle-income countries: the ACT cluster-randomised trial. Lancet. 2015;385(9968):629–39. doi: 10.1016/S0140-6736(14)61651-2.
- Althabe F, Belizan J, Mazzoni A, Berrueta M, Hemingway-Foday J, Koso-Thomas M, et al. Antenatal corticosteroids trial in preterm births to increase neonatal survival in developing countries: study protocol. Reprod Health. 2012;9:22.
- Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn JE. Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol. 2010;39(suppl 1):i122–33. doi: 10.1093/ije/dyq029.
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006;3
- Manasyan A, Saleem S, Koso-Thomas M, Althabe F, Pasha O, Chomba E, Goudar SS, Patel A, Esamai F, Garces A, Kodkany B, Belizan J, McClure EM, Derman RJ, Hibberd P, Liechty EA, Hambidge KM, Carlo WA, Buekens P, Moore J, Wright LL, EmONC Trial Group. Goldenberg RL. Assessment of obstetric and neonatal health services in developing country health facilities. Am J Perinatol. 2013;30(9):787–94. doi: 10.1055/s-0032-1333409.
- McClure EM, Saleem S, Goudar SS, Moore JL, Garces A, Esamai F, et al. Stillbirth rates in low-middle income countries 2010–2013: a population-based, multi-country study from the Global Network. Reprod Health. 2015;12(Suppl 2):S7. doi: 10.1186/1742-4755-12-S2-S7.
- Althabe F, Berrueta M, Hemingway-Foday J, Mazzoni A, Bonorino CA, Gowdak A, Gibbons L, et al. A color-coded tape for uterine height measurement: a tool to identify preterm pregnancies in low resource settings. PLoS One. 2015;10(3) doi: 10.1371/journal.pone.0117134.
- Goldenberg RL, McClure EM, Kodkany B, Wembodinga G, Pasha O, Esamai F, Tshefu A, Patel A, Mabaye H, Goudar S, Saleem S, Waikar M, Langer A, Bose CL, Rubens CE, Wright LL, Moore J, Blanc A. A multi-country study of the “intrapartum stillbirth and early neonatal death indicator” in hospitals in low-resource settings. Int J Gynaecol Obstet. 2013;122(3):230–3. doi: 10.1016/j.ijgo.2013.04.008.
- Turnbull E, Lembalemba MK, Guffey MB, Bolton-Moore C, Mubiana-Mbewe M, Chintu N, et al. Causes of stillbirth, neonatal death and early childhood death in rural Zambia by verbal autopsy assessments. Trop Med Int Health. 2011;16(7):894–901. doi: 10.1111/j.1365-3156.2011.02776.x.
- Bose CL, Bauserman M, Goldenberg RL, Goudar SS, McClure EM, Pasha O, Carlo WA, Garces A, Moore JL, Miodovnik M, Koso-Thomas M. The global network maternal newborn health registry: a multi-national, community-based registry of pregnancy outcomes. Reprod Health. 2015;12(Suppl 2):S1. doi: 10.1186/1742-4755-12-S2-S1.
- Morken NH, Källen K, Jacobsson B. Predicting risk of spontaneous preterm delivery in women with a singleton pregnancy. Paediatr Perinat Epidemiol. 2014;28(1):11–22. doi: 10.1111/ppe.12087.
- Goldenberg RL, Iams JD, Mercer BM, Meis PJ, Moawad AH, Copper RL, et al. The preterm prediction study: the value of new vs standard risk factors in predicting early and all spontaneous preterm births. NICHD MFMU Network. Am J Public Health. 1998;88(2):233–8. doi: 10.2105/AJPH.88.2.233.
- McLaughlin KJ, Crowther CA, Walker N, Harding JE. Effects of a single course of corticosteroids given more than 7 days before birth: a systematic review. Aust N Z J Obstet Gynaecol. 2003;43(2):101–6. doi: 10.1046/j.0004-8666.2003.00052.x.
Source: PubMed